Entry Detail



General Information

Database ID:exR0089795
RNA Name:hsa-miR-362-3p
RNA Type:miRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):50009005End Site(bp):50009026
External Links:hsa-miR-362-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
PTPRJ
chr11
47980558
48170841
+
KIAA0232
chr4
6781375
6884170
+
USF2
chr19
35268962
35279821
+
BLCAP
chr20
37492472
37527931
-
AC009133.6
chr16
29812261
29820092
+
WDR82
chr3
52254434
52288020
-
PIP4K2B
chr17
38765689
38800126
-
ARF3
chr12
48935723
48957487
-
TRPS1
chr8
115408496
115809673
-
UBTF
chr17
44205033
44221626
-
FAM126B
chr2
200973718
201071671
-
ZBTB2
chr6
151364115
151391559
-
TNFRSF21
chr6
47231532
47309905
-
RUNX1
chr21
34787801
36004667
-
MTPN
chr7
135926760
135977359
-
SERTAD3
chr19
40440844
40444335
-
DCBLD2
chr3
98795941
98901695
-
ATP8B1
chr18
57646426
57803315
-
SLF2
chr10
100912963
100965134
+
SDCBP
chr8
58552924
58582859
+
TNFRSF1B
chr1
12166991
12209228
+
COQ8A
chr1
226897536
226987545
+
DNAJB9
chr7
108569867
108574850
+
VAMP2
chr17
8159149
8163546
-
SIK1B
chr21
6111131
6123778
+
SMAP2
chr1
40344850
40423326
+
FAM219A
chr9
34398184
34458570
-
CA12
chr15
63321378
63381846
-
CALM1
chr14
90396502
90408268
+
AKAP11
chr13
42272152
42323261
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001588
chr6
26204839
26205043
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
KCNQ1OT1
chr11
2608328
2699994
-
MIR663AHG
chr20
26167817
26251546
-
NEAT1
chr11
65422774
65445540
+
SCARNA9
chr11
93721513
93721865
+
SNHG25
chr17
64145970
64146476
+
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.